1.43
-0.06(-4.03%)
Currency In USD
| Previous Close | 1.49 |
| Open | 1.51 |
| Day High | 1.56 |
| Day Low | 1.4 |
| 52-Week High | 19.51 |
| 52-Week Low | 0.51 |
| Volume | 133,033 |
| Average Volume | 343,222 |
| Market Cap | 49.74M |
| PE | -7.94 |
| EPS | -0.18 |
| Moving Average 50 Days | 1.54 |
| Moving Average 200 Days | 2.35 |
| Change | -0.06 |
If you invested $1000 in JUPITER NEUROSCIENCES, INC. (JUNS) since IPO date, it would be worth $0 as of September 18, 2025 at a share price of $1.43. Whereas If you bought $1000 worth of JUPITER NEUROSCIENCES, INC. (JUNS) shares 0 years ago, it would be worth $260.47 as of September 18, 2025 at a share price of $1.43.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador
GlobeNewswire Inc.
Sep 15, 2025 12:00 PM GMT
Partnership strengthens Nugevia™ launch bringing clinical and scientific integrity to the fast-growing longevity space Jupiter, Florida, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS) today announced that Jean Fallaca
Jupiter Neurosciences Launches Nugevia™ Website and Opens Pre-Orders for Groundbreaking Longevity Supplements
GlobeNewswire Inc.
Aug 26, 2025 12:00 PM GMT
Targeting the Multi-Trillion Dollar Longevity Market Jupiter, Florida, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company pioneering therapies for centr
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador
GlobeNewswire Inc.
Aug 19, 2025 12:12 PM GMT
Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) today announced th